These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34067074)

  • 1. Interleukin-32θ Triggers Cellular Senescence and Reduces Sensitivity to Doxorubicin-Mediated Cytotoxicity in MDA-MB-231 Cells.
    Pham TH; Park HM; Kim J; Hong JT; Yoon DY
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer.
    Pham TH; Bak Y; Kwon T; Kwon SB; Oh JW; Park JH; Choi YK; Hong JT; Yoon DY
    Cell Commun Signal; 2019 May; 17(1):53. PubMed ID: 31126309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenoside Rh2 Ameliorates Doxorubicin-Induced Senescence Bystander Effect in Breast Carcinoma Cell MDA-MB-231 and Normal Epithelial Cell MCF-10A.
    Hou JG; Jeon BM; Yun YJ; Cui CH; Kim SC
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory effects of point-mutated IL-32θ (A94V) on tumor progression in triple-negative breast cancer cells.
    Park HM; Park JY; Kim NY; Kim J; Pham TH; Hong JT; Yoon DY
    Biofactors; 2024; 50(2):294-310. PubMed ID: 37658685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel indenone derivative selectively induces senescence in MDA-MB-231 (breast adenocarcinoma) cells.
    Priyanga J; Sharan Kumar B; Mahalakshmi R; Nirekshana K; Vinoth P; Sridharan V; Bhakta-Guha D; Guha G
    Chem Biol Interact; 2020 Nov; 331():109250. PubMed ID: 32956706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different sensitivities of senescent breast cancer cells to immune cell-mediated cytotoxicity.
    Inao T; Kotani H; Iida Y; Kartika ID; Okimoto T; Tanino R; Shiba E; Harada M
    Cancer Sci; 2019 Sep; 110(9):2690-2699. PubMed ID: 31250942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Autophagic Flux in Escapers from Doxorubicin-Induced Senescence/Polyploidy of Breast Cancer Cells.
    Bojko A; Staniak K; Czarnecka-Herok J; Sunderland P; Dudkowska M; Śliwińska MA; Salmina K; Sikora E
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32846959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of osteopontin expression by RNA interference affects cell proliferation and chemotherapy sensitivity of breast cancer MDA-MB-231 cells.
    Yang L; Wei L; Zhao W; Wang X; Zheng G; Zheng M; Song X; Zuo W
    Mol Med Rep; 2012 Feb; 5(2):373-6. PubMed ID: 22143930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth factors and chemotherapeutic modulation of breast cancer cells.
    Ciftci K; Su J; Trovitch PB
    J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulforaphane induces autophagy by inhibition of HDAC6-mediated PTEN activation in triple negative breast cancer cells.
    Yang F; Wang F; Liu Y; Wang S; Li X; Huang Y; Xia Y; Cao C
    Life Sci; 2018 Nov; 213():149-157. PubMed ID: 30352240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.
    Ortiz-Montero P; Londoño-Vallejo A; Vernot JP
    Cell Commun Signal; 2017 May; 15(1):17. PubMed ID: 28472950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditioned medium from stimulated macrophages inhibits growth but induces an inflammatory phenotype in breast cancer cells.
    Song W; Thakor P; Vesey DA; Gobe GC; Morais C
    Biomed Pharmacother; 2018 Oct; 106():247-254. PubMed ID: 29966967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Second-Generation Proteasome Inhibitor and Doxorubicin Modulates IL-6, pSTAT-3 and NF-kB Activity in MDA-MB-231 Breast Cancer Cells.
    Vyas D; Lopez-Hisijos N; Shah P; Deshpande KS; Basson MD; Vyas A; Chaturvedi LS
    J Nanosci Nanotechnol; 2017 Jan; 17(1):175-85. PubMed ID: 29617099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-32θ inhibits monocytic differentiation of leukemia cells by attenuating expression of transcription factor PU.1.
    Kim MS; Kang JW; Park YS; Lee DH; Bak Y; Kwon T; Yoon DY
    Oncotarget; 2015 Feb; 6(6):4394-405. PubMed ID: 25726525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel camptothecin derivative, CPT211, induces cell cycle arrest and apoptosis in models of human breast cancer.
    Chiu CF; Lin YQ; Park JM; Chen YC; Hung SW; Chiu CC; Chang CF
    Biomed Pharmacother; 2020 Aug; 128():110309. PubMed ID: 32505820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEMF Potentiates Doxorubicin-induced Late G
    Woo SH; Jung BC; Kim JY; Lee YH; Kim YS
    Anticancer Res; 2024 Jul; 44(7):2837-2846. PubMed ID: 38925852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer.
    Bak Y; Kwon T; Bak IS; Hong J; Yu DY; Yoon DY
    Oncotarget; 2016 Feb; 7(6):7307-17. PubMed ID: 26824417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of
    Asadi-Samani M; Rafieian-Kopaei M; Lorigooini Z; Shirzad H
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30459240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C
    Chang WT; Wu CY; Lin YC; Wu MT; Su KL; Yuan SS; Wang HD; Fong Y; Lin YH; Chiu CC
    Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31480728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.